Annotation Detail for LZTS1

Basic Information
Top
Pathway ID | Pathway Name |
---|
| Transcription |
Desease ID | Desease Name |
---|
1831 | Prostate cancer |
1976 | Squamous cell cancer |
2200 | Intraocular melanoma |
2237 | Neoplasm metastasis |
Desease Name |
---|
prostate cancer |
CANCER |
PSYCH |
major depressive disorder (broad) |
Desease Name |
---|
Esophageal squamous cell carcinoma |
Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C016403 |
2,4-dinitrotoluene |
2,4-dinitrotoluene affects the expression of LZTS1 mRNA | affects expression | 21346803
|
D000643 |
Ammonium Chloride |
Ammonium Chloride affects the expression of LZTS1 mRNA | affects expression | 16483693
|
D002117 |
Calcitriol |
Calcitriol results in increased expression of LZTS1 mRNA | increases expression | 16002434
|
D005419 |
Flavonoids |
Flavonoids results in increased expression of LZTS1 mRNA | increases expression | 18035473
|
C065180 |
fluvastatin |
[zoledronic acid co-treated with fluvastatin] results in increased expression of LZTS1 mRNA | affects cotreatment|increases expression | 16996129
|
D015739 |
Nocodazole |
LZTS1 protein affects the susceptibility to Nocodazole | affects response to substance | 17349584
|
C088658 |
zoledronic acid |
[zoledronic acid co-treated with fluvastatin] results in increased expression of LZTS1 mRNA | affects cotreatment|increases expression | 16996129
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000138 |
Acidosis |
|
Ammonium Chloride |
3.95 | 18287403 |
MESH:D058186 |
Acute Kidney Injury |
|
zoledronic acid |
4.74 | 19715164 |
MESH:D000210 |
Acute-Phase Reaction |
|
zoledronic acid |
5.88 | 20200999 |
MESH:D001859 |
Bone Neoplasms |
|
zoledronic acid |
5.26 | 19442620 16778634 11697798 15867366 16121404 17312309 |
MESH:D001862 |
Bone Resorption |
|
zoledronic acid |
4.98 | 18496637 11869084 8053405 15845617 16769263 18404659 |
MESH:D001943 |
Breast Neoplasms |
|
Calcitriol |
2.67 | 11237771 |
MESH:D001943 |
Breast Neoplasms |
|
zoledronic acid |
2.67 | 16096432 18695136 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
2,4-dinitrotoluene |
1.78 | 16705839 |
MESH:D002289 |
Carcinoma, Non-Small-Cell Lung |
|
zoledronic acid |
3.62 | 19233551 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
zoledronic acid |
3.96 | 18507039 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Calcitriol |
2.68 | 11237771 |
MESH:D003327 |
Coronary Disease |
|
fluvastatin |
4.97 | 16142594 |
MESH:D003490 |
Cyanosis |
|
2,4-dinitrotoluene |
4.37 | 18551238 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
2,4-dinitrotoluene |
2.03 | 18551238 21346803 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Calcitriol |
4.26 | 15138306 |
MESH:D004938 |
Esophageal Neoplasms |
marker/mechanism |
|
| |
MESH:D005264 |
Femoral Fractures |
|
zoledronic acid |
6.22 | 16234978 |
MESH:D006930 |
Hyperalgesia |
|
zoledronic acid |
4.47 | 16769263 |
MESH:D006934 |
Hypercalcemia |
|
zoledronic acid |
5.33 | 19622757 18089816 |
MESH:D006996 |
Hypocalcemia |
|
zoledronic acid |
6.64 | 12669777 |
MESH:D007249 |
Inflammation |
|
Flavonoids |
2.77 | 17296493 |
MESH:D007680 |
Kidney Neoplasms |
|
2,4-dinitrotoluene |
3.21 | 16705839 |
MESH:D015459 |
Leukemia-Lymphoma, Adult T-Cell |
|
zoledronic acid |
5.05 | 18089816 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
zoledronic acid |
3.88 | 17312309 |
MESH:D008654 |
Mesothelioma |
|
zoledronic acid |
3.84 | 16675582 |
MESH:D009101 |
Multiple Myeloma |
|
fluvastatin |
8.81 | 16996129 |
MESH:D009101 |
Multiple Myeloma |
|
zoledronic acid |
8.81 | 18089719 16996129 19621390 |
MESH:D009336 |
Necrosis |
|
2,4-dinitrotoluene |
4.25 | 18551238 |
MESH:D009362 |
Neoplasm Metastasis |
|
zoledronic acid |
3.73 | 15867366 17312309 19139120 |
MESH:D009784 |
Occupational Diseases |
|
2,4-dinitrotoluene |
3.69 | 16049721 12819281 |
MESH:D010014 |
Osteolysis |
|
zoledronic acid |
5.77 | 15867366 |
MESH:D010024 |
Osteoporosis |
|
zoledronic acid |
4.19 | 17882678 |
MESH:D010146 |
Pain |
|
zoledronic acid |
4.17 | 16475674 |
MESH:D011470 |
Prostatic Hyperplasia |
|
Calcitriol |
5.18 | 15572423 |
MESH:D011471 |
Prostatic Neoplasms |
marker/mechanism |
|
| 12377406 |
MESH:D011471 |
Prostatic Neoplasms |
|
Calcitriol |
3.68 | 18247401 16644109 12479363 16289102 15754350 |
MESH:D011471 |
Prostatic Neoplasms |
|
zoledronic acid |
3.68 | 19103299 12438248 |
MESH:D012512 |
Sarcoma, Ewing's |
|
zoledronic acid |
5.26 | 16121404 |
MESH:D012640 |
Seizures |
|
2,4-dinitrotoluene |
2.71 | 18551238 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
2,4-dinitrotoluene |
2.37 | 16049721 |
MESH:D014571 |
Urologic Neoplasms |
|
2,4-dinitrotoluene |
4.71 | 10091137 |